| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/20/2010 | US7700736 PRO350 antibodies |
| 04/20/2010 | US7700735 High potency recombinant antibodies and method for producing them |
| 04/20/2010 | US7700729 Modified bacteriocins and methods for their use |
| 04/20/2010 | US7700558 Methods for treating diabetes using fibroblast growth factor-like polypeptides |
| 04/20/2010 | US7700523 zinc finger motifs are randomised in overlapping regions and to smart libraries incorporating limited directed randomisation at selected position |
| 04/20/2010 | US7700345 Exopolysaccharide hyper-producing cells unresponsive to modulator of bacterial exopolysaccharide biosynthesis |
| 04/20/2010 | US7700341 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 04/20/2010 | US7700339 Echinoderm Microtubule-Associated Protein-Like 4 (EML-4); Anaplastic Lymphoma Kinase (ALK); non-small cell lung carcinoma (NSCLC) |
| 04/20/2010 | US7700337 Process for constructing strain having compactin hydroxylation ability |
| 04/20/2010 | US7700328 Using vector transformation to generate transgenic enteric microorganism which overexpresses tyrosine; for enhancing animal feeds; for use in anti-Parkinson's drug |
| 04/20/2010 | US7700322 provide alternative host cells comprising multiple copies of a gene of interest, which cells are devoid of antibiotic markers, for use in the industrial production of polypeptides in high yields |
| 04/20/2010 | US7700321 producing a glycosylated monoclonal antibody or Fc fusion protein by culturing the cell in the presence of kifunensine ; for targeted killing of cells in a mammal, including therapeutic methods of treating cancers, autoimmune diseases and other diseases |
| 04/20/2010 | US7700318 polypeptide comprising a TNF neutralizer domain, an IL-1 receptor antagonist domain, and a dimerization domain; rheumatoid arthritis or psoriasis |
| 04/20/2010 | US7700317 glycoprotein comprising the extracellular domain of a non-naturally occurring BAFF-R; BAFF (B-cell-activating factor of the TNF family); immunologic, autoimmune diseases, cancers, virus-associated diseases, renal, hypertensive diseases, conditions requiring immunosuppression, inflammation |
| 04/20/2010 | US7700316 CD109 nucleic acid molecules, polypeptides and methods of use |
| 04/20/2010 | US7700315 Comprises nucleotide sequences coding polypeptide with serine protease activity for use in identifying modulator and treaments for blood coagulation and cell proliferative disorders |
| 04/20/2010 | US7700314 Method for producing polyol-IFN-β conjugate |
| 04/20/2010 | US7700303 Biosensors, method for obtaining the same and uses thereof |
| 04/20/2010 | US7700297 Artery- and vein-specific proteins and uses therefor |
| 04/20/2010 | US7700272 Ligand gated chloride channel for use as screening tool in identifying/screening pesticidal and antiparasitic agents |
| 04/20/2010 | US7700271 Method of diagnosis and treatment and agents useful for same |
| 04/20/2010 | US7700119 85kDa neisserial antigen |
| 04/20/2010 | US7700117 Camp factor of Streptococcus uberis |
| 04/20/2010 | US7700114 original codons are exchanged by codons which lead to an enhanced translation in a mammalian cell, contain a deletion resulting in the production of a truncated non-functional protein; capable of enhancing the immunogenicity |
| 04/20/2010 | US7700109 Biomolecule transduction motif Mph-1-BTM and the use thereof |
| 04/20/2010 | US7700107 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid β for induction of an immune response to amyloid β and amyloid deposits |
| 04/20/2010 | US7700100 FcγRIIB fusion proteins and compositions thereof |
| 04/20/2010 | US7700097 Purification and preferential synthesis of binding molecules |
| 04/20/2010 | US7700095 Detection, isolation and uses of renalase (monoamine oxidase c) |
| 04/20/2010 | US7700088 Interleukin-9 mutein peptides |
| 04/20/2010 | CA2421058C Protein hydrolysates produced with the use of marine proteases |
| 04/20/2010 | CA2377468C Peptide acceptor ligation methods |
| 04/20/2010 | CA2330549C Diacylglycerol o-acyltransferase |
| 04/20/2010 | CA2318486C Novel nucleic acid molecules correlated with the rhesus weak d phenotype |
| 04/20/2010 | CA2287541C Regulatory system for inducible expression of genes with lambdoid promoters |
| 04/20/2010 | CA2219876C Stable variant hk2 polypeptide |
| 04/20/2010 | CA2191884C Novel glycoglycerophospholipid, antibody thereagainst, and method for detecting mycoplasma |
| 04/20/2010 | CA2180872C Composition containing nucleic acids, preparation and uses |
| 04/20/2010 | CA2155303C Treatment for insulin dependent diabetes |
| 04/20/2010 | CA2134756C Selectin variants |
| 04/15/2010 | WO2010042728A1 Small molecule modulators of prongf uptake |
| 04/15/2010 | WO2010042705A1 Antibody formulation |
| 04/15/2010 | WO2010042333A1 Generation of mitotic phase reporter for in vivo bioluminescence imaging in living animals |
| 04/15/2010 | WO2010040480A1 Small scale shaker flask cultivation |
| 04/15/2010 | WO2009080299A8 Sm-protein based secretion engineering |
| 04/15/2010 | WO2009026716A8 Method for cellulase production |
| 04/15/2010 | US20100095398 Protection against environmental toxicity through manipulation of the processing of messenger RNA precursors |
| 04/15/2010 | US20100095390 Aldolases, Nucleic Acids Encoding Them and Methods for Making and Using Them |
| 04/15/2010 | US20100093841 Cell culture system of a hepatitis c genotype 3a and 2a chimera |
| 04/15/2010 | US20100093642 Novel polypeptides |
| 04/15/2010 | US20100093640 Ace-inhibitory peptides from whey and methods for providing the same |
| 04/15/2010 | US20100093633 Polypeptides having antimicrobial activity |
| 04/15/2010 | US20100093629 Genes and polypeptides relating to human pancreatic cancers |
| 04/15/2010 | US20100093627 Albumin fusion proteins |
| 04/15/2010 | US20100093615 Antibacterial compounds and processes for its production |
| 04/15/2010 | US20100093608 Modified animal erythropoietin polypeptides and their uses |
| 04/15/2010 | US20100093040 Modified beta-glucosidases with improved stability |
| 04/15/2010 | US20100093039 Cell Culture Media for Enhanced Protein Production |
| 04/15/2010 | US20100093038 Means and Methods for Influencing the Stability of Cells |
| 04/15/2010 | US20100093037 Growth of microorganisms in media containing soy components |
| 04/15/2010 | US20100093034 Alkaline Bacillus Amylase |
| 04/15/2010 | US20100093033 Inducible mutagenesis of target genes |
| 04/15/2010 | US20100093032 Modified Microorganism |
| 04/15/2010 | US20100093031 Dna encoding xylitol dehydrogenase |
| 04/15/2010 | US20100093030 Production of secreted proteins by filamentous fungi |
| 04/15/2010 | US20100093029 Modified luciola cruciata luciferase gene and protein |
| 04/15/2010 | US20100093028 Modified variant bowman birk protease inhibitors |
| 04/15/2010 | US20100093027 3-phosphoinositide-dependent protein kinase that phosphorylates and activates protein kinase B alpha; drug target for cancer; drug screening for enzyme inhibitors as anticancer agents |
| 04/15/2010 | US20100093026 Novel endoribonuclease |
| 04/15/2010 | US20100093025 Method for producing a yeast extract |
| 04/15/2010 | US20100093024 Cell-free synthesis of proteins containing unnatural amino acids |
| 04/15/2010 | US20100093002 Diagnosis and treatment of malignant neoplasms |
| 04/15/2010 | US20100092997 Method of Enhancing of Binding Activity of Antibody Composition to FcGamma Receptor IIIa |
| 04/15/2010 | US20100092976 Thermostable duplex-specific nuclease |
| 04/15/2010 | US20100092941 32142,21481,25964,21686, Novel dehydrogenase molecules and uses therefor |
| 04/15/2010 | US20100092613 Cloning and expression of a novel phytase |
| 04/15/2010 | US20100092521 Antigenicity of infectious pancreatic necrosis virus vp2 sub-viral particles expressed in yeast |
| 04/15/2010 | US20100092520 Recombinant Plasmodium Falciparum Merozoite Surface Proteins 4 and 5 and Their Use |
| 04/15/2010 | US20100092503 Hcv fusion polypeptideds |
| 04/15/2010 | US20100092470 Antibodies, analogs and uses thereof |
| 04/15/2010 | US20100092460 Amino acid sequences directed against chemokines and polypeptides comprising the same for the treatment of chemokine-related diseases and disorders |
| 04/15/2010 | US20100092455 Novel anti-proliferation antibodies |
| 04/15/2010 | US20100092437 Radiation inducible promoter |
| 04/15/2010 | US20100092431 Edwardsiella Ictaluri Bacteriophage and Uses Thereof |
| 04/15/2010 | US20100092423 Pharmaceutical composition comprising an anti-cd6 monoclonal antibody used in the diagnosis and treatment of rheumatoid arthritis |
| 04/15/2010 | DE102008051574A1 Method for extracting a protein with interferon-beta-activity, comprises culturing cells with the ability to synthesize the protein in a culture medium containing a block copolymer of ethylene oxide and propylene oxide |
| 04/15/2010 | CA2737642A1 Small scale shaker flask cultivation |
| 04/14/2010 | EP2175017A1 Pseudomonas aeruginosa outer membrane protein pa4710 |
| 04/14/2010 | EP2175013A1 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
| 04/14/2010 | EP2174958A1 Antibodies derived from anti ed-b l19 and targeting tumor vasculature |
| 04/14/2010 | EP2174955A1 Ifnar2 muteins, their production and use |
| 04/14/2010 | EP2174953A1 Compositions and methods for the diagnosis and treatment of tumor |
| 04/14/2010 | EP2174950A1 fermentation process for the production of diphtheria toxin |
| 04/14/2010 | EP2174946A1 Methods for chemically synthesizing immunoglobulin chimeric proteins |
| 04/14/2010 | EP2173890A1 Biological active proteins having increased in vivo and/or vitro stability |
| 04/14/2010 | EP2173860A1 Culture medium for eukaryotic cells |
| 04/14/2010 | EP1513397B1 Transgenic ungulates capable of human antibody production |
| 04/14/2010 | EP1423704B1 Diagnostic and therapeutic use of f-box proteins for alzheimer's disease and related neurodegenerative disorders |
| 04/14/2010 | EP1409016B1 Antibodies to opgl |
| 04/14/2010 | EP1399483B1 Antibodies to insulin-like growth factor i receptor |